跳至主要内容
临床试验/CTRI/2024/08/071857
CTRI/2024/08/071857尚未招募3 期

Comparative Clinical Study to Evaluate the Effect of Karchura arka (Curcuma zedoaria Rosc.) and Parnayavani arka (Coleus aromaticus Benth.) in Tamaka shwasa vis-a-vis Bronchial Asthma

Government Ayurveda Medical College1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年8月11日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Assessment of Subjective parameters will be done based on classical symptoms of Tamaka Shwasa

研究概览

简要总结

Tamaka Shwasa is charecterized as a disorder of Pranavaha srotas resulting from the imbalance of Vata Kapha doshas, which manifests symptoms like Peenasa Ghurghuraka shabdha etc. According to WHO, Global surveys have indicated that over 262 million individuals worldwide are affected by Bronchial Asthma with a Prevalence rate ranging from 2-5 percent in India. Upon assessing the breathing patterns and pathological alterations Bronchial Asthma closely mirrors the charecteristics of Tamaka Shwasa. The concept of Arka as a dosage form is widely used in modern times due to its reduced dosing requirements enhanced patient adherence and amplified potency. Given the higher prevalence of Asthma there is a growing need to diversify treatment options within the field of Ayurveda. In this context Arka Kalpana assumes a pivotal role due to its palatability and rapid assimilation compared to other formulations. The drugs Karchura and Parnayavani with their rich volatile components can indeed play a significant role in treating Tamaka Shwasa when prepared in the form of Arka.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Subjects having classical symptoms of Tamaka Shwasa with atleast 3 symptoms and for a duration of atleast 3 months are selected for the study Subjects who are willing to be a part of research work and are ready to sign the written consent will be selected Mild to Moderate condition according to GINA parameters Peak Expiratory Flow Rate within 60 to 90 percentage.

排除标准

  • Peak Expiratory Flow Rate less than 60 percentage History of any Cardiac involvement Cyanosis Uncontrolled Diabetes Mellitus and Hypertension Pregnant and Lactating women Any anatomical defect in airway and other complicated respiratory disorders like TB Emphysema Bronchiectasis Carcinoma etc.

结局指标

主要结局

Assessment of Subjective parameters will be done based on classical symptoms of Tamaka Shwasa

时间窗: 15days

Assessment of Objective parameters will be done based on Auscultation Peak Expiratory Flow Rate

时间窗: 15days

次要结局

  • Assessment of Severity will be done Before Treatment After Treatment & during the Follow up(22 days)

研究者

发起方
Government Ayurveda Medical College
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Nagashree S

Government Ayurveda Medical College

研究点 (1)

Loading locations...

相似试验